The global market for biological safety testing is expected to witness tremendous growth in the forthcoming period. Some prominent factors are contributing significantly to the market’s growth, such as increasing awareness towards medicare and healthcare in developing countries, rising old age population, and growing incidence of cancer across the world. Furthermore, the rising need for biologics has resulted in remarkable growth in the number of biopharmaceutical companies. Companies are taking efforts to develop therapeutically advanced drugs on a large scale along with improving productivity and cost-efficiency. Therefore, companies are implementing good manufacturing practices involving exhaustive biological testing at various levels of the production cycle. Thus, the increasing use of biological safety testing in the biotechnology and pharmaceutical industries is positively impacting the overall growth of the market.
Moreover, according to the FDA, the number of new biologics approved in the US increased from 22 in 2016 to 48 in 2019. Hence, rising investments by biopharmaceutical companies to develop biologics and biosimilars are further projected to increase the number of approved products across the globe. This fact eventually boosting the growth of the biological safety testing market over the forecast period. As well, the rising number of government initiatives to promote biological safety testing products and services is expected to drive the overall growth of the market in near future.
Biological Safety Testing Market Segment Overview
Based on the product, the reagents & kits segment is expected to witness remarkable growth in the market. This is because of the increasing popularity and introduction of more effective and innovative technologies by the leading companies operating in the global market. Additionally, the services segment has the largest share of the market. This is due to the limited finances of biopharmaceutical manufacturers, complex manufacturing requirements, large investments required for establishing manufacturing facilities, and others, all of which have prompted the shift towards the outsourcing of biologics safety testing to service providers.
Biological Safety Testing Regional Overview
North America holds the major share of the biological safety testing market and this trend is expected to continue during the forecast period. This is attributed to high investments in biotechnology and the development of new biologics, vaccines, & drugs in the region. In addition, increasing investment for R&D by companies is one of the key factors responsible for the market’s growth. Europe is the second big region for the biological safety testing market. Similarly, the Asia Pacific is expected to register the fastest growth during the forecast period. Various factors such as rising healthcare expenditure and increasing awareness about the benefits of these products are expected to fuel the growth of the market in this region. Moreover, Latin America is projected to expand at a sluggish pace in the near future. This is due to the increasing awareness about these biological safety devices and the huge presence of leading manufacturers in the region.
Biological Safety Testing Market, Key Players
· NuAire
· Paragon Bioservices Inc.
· Nordic Scientific & Natural Solutions
· Toxikon Inc.
· SGS SA
· Charles River Laboratories International, Inc.
· BSL Bioservice Scientific Laboratories GmbH
· Lonza Group AG
· Milliporesigma
· Sartorius Stedim BioOutsource Limited
· Samsung BioLogics
Biological Safety Testing Market Segmentation
Biological Safety Testing Market, By Product
· Reagents & kits
· Instruments
· Services
Biological Safety Testing Market, By Application
· Vaccines & Therapeutics
· Blood & Blood-based Products
· Gene Therapy
· Tissue & Tissue-based Products
· Stem Cell
Biological Safety Testing Market, By Test Type
· Endotoxin Tests
· Sterility Tests
· Cell Line Authentication & Characterization Tests
· Bioburden Tests
· Adventitious Agent Detection Tests
· Residual Host Contamination Detection Tests
· Others
Biological Safety Testing Market, By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Reagents & kits
- 5.2.2. Instruments
- 5.2.3. Services
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Vaccines & Therapeutics
- 5.3.2. Blood & Blood-based Products
- 5.3.3. Gene Therapy
- 5.3.4. Tissue & Tissue-based Products
- 5.3.5. Stem Cell
- 5.4. Market Analysis, Insights and Forecast – By Test Type
- 5.4.1. Endotoxin Tests
- 5.4.2. Sterility Tests
- 5.4.3. Cell Line Authentication & Characterization Tests
- 5.4.4. Bioburden Tests
- 5.4.5. Adventitious Agent Detection Tests
- 5.4.6. Residual Host Contamination Detection Tests
- 5.4.7. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Reagents & kits
- 6.2.2. Instruments
- 6.2.3. Services
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Vaccines & Therapeutics
- 6.3.2. Blood & Blood-based Products
- 6.3.3. Gene Therapy
- 6.3.4. Tissue & Tissue-based Products
- 6.3.5. Stem Cell
- 6.4. Market Analysis, Insights and Forecast – By Test Type
- 6.4.1. Endotoxin Tests
- 6.4.2. Sterility Tests
- 6.4.3. Cell Line Authentication & Characterization Tests
- 6.4.4. Bioburden Tests
- 6.4.5. Adventitious Agent Detection Tests
- 6.4.6. Residual Host Contamination Detection Tests
- 6.4.7. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Reagents & kits
- 7.2.2. Instruments
- 7.2.3. Services
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Vaccines & Therapeutics
- 7.3.2. Blood & Blood-based Products
- 7.3.3. Gene Therapy
- 7.3.4. Tissue & Tissue-based Products
- 7.3.5. Stem Cell
- 7.4. Market Analysis, Insights and Forecast – By Test Type
- 7.4.1. Endotoxin Tests
- 7.4.2. Sterility Tests
- 7.4.3. Cell Line Authentication & Characterization Tests
- 7.4.4. Bioburden Tests
- 7.4.5. Adventitious Agent Detection Tests
- 7.4.6. Residual Host Contamination Detection Tests
- 7.4.7. Others
- 7.5. Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Reagents & kits
- 8.2.2. Instruments
- 8.2.3. Services
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Vaccines & Therapeutics
- 8.3.2. Blood & Blood-based Products
- 8.3.3. Gene Therapy
- 8.3.4. Tissue & Tissue-based Products
- 8.3.5. Stem Cell
- 8.4. Market Analysis, Insights and Forecast – By Test Type
- 8.4.1. Endotoxin Tests
- 8.4.2. Sterility Tests
- 8.4.3. Cell Line Authentication & Characterization Tests
- 8.4.4. Bioburden Tests
- 8.4.5. Adventitious Agent Detection Tests
- 8.4.6. Residual Host Contamination Detection Tests
- 8.4.7. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Reagents & kits
- 9.2.2. Instruments
- 9.2.3. Services
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Vaccines & Therapeutics
- 9.3.2. Blood & Blood-based Products
- 9.3.3. Gene Therapy
- 9.3.4. Tissue & Tissue-based Products
- 9.3.5. Stem Cell
- 9.4. Market Analysis, Insights and Forecast – By Test Type
- 9.4.1. Endotoxin Tests
- 9.4.2. Sterility Tests
- 9.4.3. Cell Line Authentication & Characterization Tests
- 9.4.4. Bioburden Tests
- 9.4.5. Adventitious Agent Detection Tests
- 9.4.6. Residual Host Contamination Detection Tests
- 9.4.7. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa Biological Safety Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Product
- 10.2.1. Reagents & kits
- 10.2.2. Instruments
- 10.2.3. Services
- 10.3. Market Analysis, Insights and Forecast – By Application
- 10.3.1. Vaccines & Therapeutics
- 10.3.2. Blood & Blood-based Products
- 10.3.3. Gene Therapy
- 10.3.4. Tissue & Tissue-based Products
- 10.3.5. Stem Cell
- 10.4. Market Analysis, Insights and Forecast – By Test Type
- 10.4.1. Endotoxin Tests
- 10.4.2. Sterility Tests
- 10.4.3. Cell Line Authentication & Characterization Tests
- 10.4.4. Bioburden Tests
- 10.4.5. Adventitious Agent Detection Tests
- 10.4.6. Residual Host Contamination Detection Tests
- 10.4.7. Others
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. NuAire
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Paragon Bioservices Inc.
- 11.6. Nordic Scientific & Natural Solutions
- 11.7. Toxikon Inc.
- 11.8. SGS SA
- 11.9. Charles River Laboratories International, Inc.
- 11.10. BSL Bioservice Scientific Laboratories GmbH
- 11.11. Lonza Group AG
- 11.12. Milliporesigma
- 11.13. Sartorius Stedim BioOutsource Limited
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
